Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Centene Corp.

Close the sale of Magellan Rx

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
26 Jul 2022
Due
31 Dec 2022
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“The transaction is expected to close by the end of 2022.”

What we found

Evidence strength A What the grades mean

The FY2022 10-K describes the Magellan Rx divestiture as completed within 2022, and later filings refer to a gain on its sale. The exact closing date is not stated.

  • A
    Centene Corporation 10-K filed 2023-02-21 Regulatory filing · published 21 Feb 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC
    “The effective tax rate for the year ended December 31, 2022 is driven by the tax effects of pending and completed divestitures and impairments associated with our ongoing portfolio review, including the Magellan Rx divestiture gain” ✓ confirmed on the page
  • A
    Centene Corporation 10-K filed 2023-02-21 Regulatory filing · published 21 Feb 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC
    “the redemption of Magellan's outstanding debt of $535 million assumed in the transaction using Magellan's cash on hand” ✓ confirmed on the page
  • A
    Centene Corporation 10-Q filed 2023-10-24 Regulatory filing · published 24 Oct 2023 · retrieved 10 Oct 2026 · kept permanently by the SEC
    “a $10 million reduction to the previously recorded gain on the sale of Magellan Rx.” ✓ confirmed on the page

Market reaction: the shares moved -0.7% against the S&P 500 over the three sessions around the disclosure (17 Feb 2023 to 23 Feb 2023). What this measures

Checked 10 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Acquisition close
Indicative materiality
High rules
Action
Close
Deliverable
Sale of Magellan Rx
Language
Expected (“expects”, “plans”)
In the company’s control
High
Specificity
High
Depends on
Counterparty

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Centene Corporation? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2022-CNC-005484 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.